Napo Pharms Inc Drug Patent Portfolio

Napo Pharms Inc owns 1 orange book drug protected by 5 US patents Given below is the list of Napo Pharms Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8962680 Methods and compositions for treating HIV-associated diarrhea 31 Oct, 2031
Active
US9585868 Methods and compositions for treating HIV-associated diarrhea 31 Oct, 2031
Active
US7341744 Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer 16 Jun, 2018 Expired
US7323195 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions 07 Jun, 2018 Expired
US8574634 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions 11 Jan, 2018 Expired


Given below is the list of recent legal activities going on the following drug patents of Napo Pharms Inc.

Activity Date Patent Number
Patent litigations
Expire Patent 13 Dec, 2021 US8574634
Maintenance Fee Reminder Mailed 28 Jun, 2021 US8574634
Payment of Maintenance Fee, 4th Yr, Small Entity 31 Aug, 2020 US9585868
Change in Power of Attorney (May Include Associate POA) 01 Jul, 2020 US9585868
Email Notification 01 Jul, 2020 US9585868
Correspondence Address Change 29 Jun, 2020 US9585868
Correspondence Address Change 29 Jun, 2020 US8574634
Expire Patent 02 Mar, 2020 US7323195
Maintenance Fee Reminder Mailed 16 Sep, 2019 US7323195
Patent Issue Date Used in PTA Calculation 07 Mar, 2017 US9585868
Recordation of Patent Grant Mailed 07 Mar, 2017 US9585868
Email Notification 16 Feb, 2017 US9585868
Issue Notification Mailed 15 Feb, 2017 US9585868
Application Is Considered Ready for Issue 31 Jan, 2017 US9585868
Dispatch to FDC 31 Jan, 2017 US9585868


Napo Pharms Inc's Family Patents

Napo Pharms Inc drugs have patent protection in a total of 20 countries. It's US patent count contributes only to 30.0% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Napo Pharms Inc Drug List

Given below is the complete list of Napo Pharms Inc's drugs and the patents protecting them.


1. Mytesi

Mytesi is protected by 5 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8962680 Methods and compositions for treating HIV-associated diarrhea 31 Oct, 2031
(7 years from now)
Active
US9585868 Methods and compositions for treating HIV-associated diarrhea 31 Oct, 2031
(7 years from now)
Active
US7341744 Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer 16 Jun, 2018
(6 years ago)
Expired
US7323195 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions 07 Jun, 2018
(6 years ago)
Expired
US8574634 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions 11 Jan, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mytesi's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List